期刊文献+

心房颤动发病机制及其治疗药物应用评价

Underlying mechanisms of atrial fibrillation and its therapeutic progress
原文传递
导出
摘要 心房颤动(AF)是临床常见的心律失常。近几十年来,随着人均寿命增加,AF发病率显著上升,且呈现出随年龄增长而增加的趋势。本综述回顾相关发病机制研究,重点分析各药物在AF治疗中的应用评价。 Atrial fibrillation (AF) is the most common arrhythmia in clinic. In recent decades, as the extended average lifespan, the incidence olAF is increasing with age. This review describes the mechanism of AF and evaluates the drug therapy in the treatment olAF.
出处 《世界临床药物》 CAS 2013年第10期634-639,共6页 World Clinical Drug
关键词 心房颤动 分子生物学 遗传学 机制 药物治疗 atrial fibrillation molecular biology genetics mechanism medication
  • 相关文献

参考文献40

  • 1Singh D,Cingolani E,Diamond GA,et al.Dronedarone for Atrial Fibrillation:Have we expanded the antiarrhythmic armamentarium[J].J Am Coil Cardiol,2010,55 (15):1569-1570.
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1397
  • 3张勇,杨宝峰.心房颤动发病机制研究进展[J].沈阳药科大学学报,2011,28(8):680-686. 被引量:12
  • 4Ambros V.The functions of animal microRNA[J].Nature,2004,431 (7006):350-355.
  • 5Yang BF,Lu YJ,Wang ZG.MicroRNAs and apoptosis:inplications in the molecular therapy of human disease[J].Clin Exp phamacol physiol,2009,36 (10):951-960.
  • 6张勇,吕延杰,杨宝峰.MicroRNA在人类疾病中的作用及其作为靶点的小分子药物设计[J].药学学报,2007,42(11):1115-1121. 被引量:17
  • 7Shan HL,Zhang Y,Lu Y,et al.Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines[J].Cardiovasc Res,2009,83 (3):465-472.
  • 8Chen Y H,Xu SJ,Bendahhou S,et al.KCNQ1 gain-of-function mutation in familial atrial fibrillation.Science,2003,299 (5604):251-254.
  • 9Xia M,Jin Q,Bendahhou S,et al.A Kir2.1gain-of-function mutation underlies familial atrial fibrillation[J].Biochem Biophys Res Commun,2005,332 (4):1012-1019.
  • 10Chen LY,Ballew JD,Herron KJ,et al.A common polymorphism in SCN5A is associated with lone atrial fibrillation[J].Clin Pharmacol Ther,2007,81 (1):35-41.

二级参考文献201

共引文献1625

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部